Navigation

dextran (Gentran, LMD, Rheomacrodex)

 

Classes: Volume Expanders

Dosing and uses of Gentran, LMD (dextran)

 

Adult dosage forms and strengths

injectable solution

  • 6% (Dextran 70)
  • 10% (Dextran 40)

 

Shock

No more than 20 mL/kg IV during first 24 hours; THEN 10 mL/kg/day

Same mL dosage for both 10% & 6%

10% Solution

  • No more than 5 days
  • First 500 mL infused rapidly, then slow infusion

 

Surgery (DVT/PE Prophylaxis)

10% Solution: 500-1000 mL (~10 mL/kg) on day of surgery; THEN 500 mL/day for 2-3 days; THEN 500 mL q2-3Days PRN up to 2 weeks

6% Solution: Not approved but used

 

Priming Fluid in Pump Oxygenators, Uterine Cavity Distention

Add 10-20 mL/kg (or 1-2 g/kg); not to exceed 20 mL/kg (2g/kg); dose varies with volume of pump oxygenator

 

Renal Impairment

Extreme caution

 

Hepatic Impairment

Extreme caution

 

Progenitor Cell Mobilization (Orphan)

Treatment to mobilze progenitor cells prior to stem cell transplantation

Orphan indication sponsor

  • TikoMed AB; P.O. Box 81 (Karlsfaltsvagen 349); SE-263 03, Viken, Sweden

 

Pancreatic Islet Transplantation (Orphan)

LMW dextran sulfate (Ibsolvmir): Prevention of graft rejection during pancreatic islet transplantation

Orphan indication sponsor

  • TikoMed AB; P.O. Box 81 (Karlsfaltsvagen 349); SE-263 03, Viken, Sweden

 

Pediatric dosage forms and strengths

injectable solution

  • 6%
  • 10%

 

10% Solution

Initial dose: 10 mL/kg IV infused rapidly, no more than 20 mL/kg/24 hours, THEN no more than 10 mL/kg/day, no more than 5 days

 

Geriatric dosage forms and strengths

 

Shock

No more than 20 mL/kg IV during first 24 hours; THEN 10 mL/kg/day

Same mL dosage for both 10% & 6%

10% solution: No more than 5 days; First 500 mL infused rapidly, then slow infusion

 

Surgery (DVT/PE prophylaxis)

10% Solution: 500-1000 mL (~10 mL/kg) on day of surgery; THEN 500 mL/day for 2-3 days; THEN 500 mL q2-3Days PRN up to 2 weeks

6% Solution: Not approved but used

 

Priming fluid in pump oxygenators, uterine cavity distention

Add 10-20 mL/kg (or 1-2 g/kg); not to exceed 20 mL/kg (2g/kg); dose varies with volume of pump oxygenator

 

Gentran, LMD (dextran) adverse (side) effects

Frequency not defined

Congestive heart failure

Mild hypotension

Tightness of chest

Thrombocytopenia

Anaphylaxis

Injection site infection/phlebitis

Acute renal failure

Acidosis (if NaCl soln used)

Pulmonary edema

Wheezing

 

Warnings

Contraindications

Hypersensitivity to dextran or corn products

Pulmonary edema, severe bleeding disorders, severe CHF, severe oliguria/anuria due to renal disease, significant hemostatic defects, cardiac decompensation

10%: Marked thrombocytopenia or hypofibrinogenemia

 

Cautions

Decreased urinary output 2nd to shock, bowel surgery, dehydration, active hemorrhage, hypernatremia, pathological abdominal conditions, thrombocytopenia

Monitor urinary output

Contains no preservatives, discard unused portions

 

Pregnancy and lactation

Pregnancy category: C

Lactation: not known if distributed into breast milk, avoid

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Gentran, LMD (dextran)

Mechanism of action

Branched polysaccharide volume expander through highly colloidal starch structure; lowers platelet & RBC adhesiveness

 

Pharmacokinetics

Elimination half-life: 40 min

Duration: 3-4hr (plasma expanding effects)

Distribution half-life: 12 min

Vd: 6.5 L

Metabolism: Minimally in tissues; liver, kidney, spleen

Excretion: urine 75%

Dialyzable: HD: No

 

Administration

IV Incompatibilities

Do not dilute or admix with other drugs

 

IV Administration

Infuse first 500 mL over 15-30 min, then slow infusion

 

Storage

Protect from freezing